News

SITEC pharmabio has been listed in The GreenTech Catalogue as a solution provider for one of the challenges related to Industrial Transition to Circular Economy. Our CO2-cryospraying technology [...]

  NutraCO2S was carried out with European partners, focusing on the use of CO2-based technologies for the recovery, processing and valorization of agro-industrial waste. For its role in the [...]

  SITEC pharmabio is in the Spanish media! Our associate director Pierandrea Esposito was interviewed by El Español. In the interview, Dr. Esposito explained the basis of our CryoXpand® [...]

Curcumin is one of the most studied natural substances for its properties as an antioxidant and anti-inflammatory agent. Because of its low solubility and rapid metabolism, curcumin has a very [...]

SITEC pharmabio has successfully completed the construction of a new, pilot-scale CO2-Cryospraying equipment to develop lipid or lipid-polymer microspheres containing active molecules from [...]

Solid Microparticles from Liquid Gases: A Novel, Dense CO2 Technology to Address Oral Drug Delivery Challenges. To be presented by: Dr. Pierandrea Esposito at: SMI 11th Annual Controlled Release [...]

Pierandrea Esposito was an invited speaker at SMI Controlled Release Delivery Conference, March 21-22, 2018 in London, (UK). He presented an overview of our latest results on the development of [...]

SiTec PharmaBio and Primex ehf partner in an R&D project to convert bioindustrial waste into high value products SiTec PharmaBio and Primex ehf, an Icelandic marine biotech company  and a [...]

SiTec PharmaBio was invited at SMI 11th Controlled Release Conference, March 12-13, 2018 in London, (UK). Pierandrea Esposito introduced our cryospraying technology based on dense carbon-dioxide [...]

Hana Danan and Pierandrea Esposito published an invited review on Therapeutic Delivery, 5,2 (2014) , discussing the most recent advancements and the potential of CO2-based technologies in [...]